FILTER
LATEST INTERVIEWS
Joseph Titus Glover
CEO, QUANTUM LC
Quantum LC describes an increasingly competitive market for mining services in Ghana but believes that local companies can succeed.
Gabriele Unger
GENERAL MANAGER, TOGETHER FOR SUSTAINABILITY (TFS)
Together for Sustainability (TfS) is expanding its efforts and reach in ensuring a sustainable supply chain for the global chemical industry.
Carlos Leigh
CEO – LATIN AMERICA, DSI UNDERGROUND
DSI Underground discusses the recovery in mining activity in Latin America following lockdowns.
Maggie Gómez Rábago
GENERAL DIRECTOR, CHARLOTTE CHEMICAL
Charlotte Chemical sets forth its expansion plans.
Federico De Simone
DIRECTOR, DE SIMONE GROUP
De Simone undertakes engineering and construction for the mining sector across West Africa.
Paul Nai
MANAGING DIRECTOR, LUBRIZOL SOUTHEAST ASIA
Lubrizol South East Asia comments on the rapidly expanding prospects in Southeast Asia.
Bernard Kaninda
AFRICA REGIONAL DIRECTOR, MAXAM
Maxam offers sophisticated blasting technology that considers all aspects of the conditions, as well as the environment that surrounds them in West Africa.
Kerry Knoll
EXECUTIVE CHAIRMAN, GENERATION MINING
Generation Mining is doing its feasibility study on its Marathon palladium project, expecting to complete permitting early 2022.
Andrew Kaip
MANAGING DIRECTOR – EQUITY RESEARCH, RED CLOUD SECURITIES
Red Cloud Securities discusses how investors’ attitude towards precious metals mining companies remains cautious despite the price increases.
Hicham Aziz
COUNTRY MANAGER, SENEGAL, SAUDEQUIP (JA DELMAS)
Saudequip is developing its Caterpillar dealership in parallel with Senegal’s fast-growing mining industry.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
